| CORBUS PHARMACEUTICALS |
| USA |
| Gesundheit |
| US21833P3010 / A3D54P |
| 3371 (Frankfurt) / CRBP (NASDAQ) |
| FRA:3371, ETR:3371, 3371:GR, NASDAQ:CRBP |
| - |
| https://www.corbuspharma... |
|
Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for oncology and obesity. The company advances a pipeline of targeted treatments, including CRB-701, a next-generation an..
>Volltext.. |
| 154.02 Mio. EUR |
| 17.44 Mio. EUR |
| - |
| -72.76 Mio. EUR |
| -67.26 Mio. EUR |
| -5.12 EUR |
| 1.4 Mio. EUR |
| 24.97 Mio. EUR |
| -55.23 Mio. EUR |
| 7.92 |
| - |
| -72.16% |
| - |
| - |
| - |
| - |
| CORBUS PHARMACEUTICALS, CORBUS PHARMA, CORBUS PHARMACEUTICAL |
| 08.04.26 |
|